Article Versions Notes

Zhou JR, Ridsdale R, MacNeil L, Lilley M, Hoang S, Christian S, Blumenschein P, Wolan V, Bruce A, Singh G, et al. The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing. International Journal of Neonatal Screening. 2021; 7(4):78. https://doi.org/10.3390/ijns7040078

Zhou, Janet R., Ross Ridsdale, Lauren MacNeil, Margaret Lilley, Stephanie Hoang, Susan Christian, Pamela Blumenschein, Vanessa Wolan, Aisha Bruce, Gurpreet Singh, and et al. 2021. "The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing" International Journal of Neonatal Screening 7, no. 4: 78. https://doi.org/10.3390/ijns7040078

Zhou, J. R., Ridsdale, R., MacNeil, L., Lilley, M., Hoang, S., Christian, S., Blumenschein, P., Wolan, V., Bruce, A., Singh, G., Wright, N., Parboosingh, J. S., Lamont, R. E., & Sosova, I. (2021). The Alberta Newborn Screening Approach for Sickle Cell Disease: The Advantages of Molecular Testing. International Journal of Neonatal Screening, 7(4), 78. https://doi.org/10.3390/ijns7040078